Skip to content
lifestyle.friendhood.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Tarsus Pharmaceuticals, Inc
Tarsus to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026
April 29, 2026
Tarsus Doses First Participant in Calliope, A Phase 2 Clinical Trial of TP-05 (lotilaner), a Novel Investigational Oral Tablet for the Potential Prevention of Lyme Disease
March 31, 2026
Tarsus to Participate in Upcoming Investor Conferences
February 26, 2026
Tarsus to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, February 23, 2026
February 17, 2026
←
Previous Page
1
2